Tks4’s involvement in tumor formation and progression across various human cancers, including melanoma (Iizuka et al., 2016), gastric carcinoma (Zhu et al., 2023), and hepatocellular carcinoma (Kui et al., 2021), has been well documented in the literature. Here, SH3PXD2B is linked to hepatocellular carcinoma.